Uri Lopatin net worth
Quick answer
Uri Lopatin's estimated net worth is $150.0M (range $105.0M – $225.0M) as of 2026. Uri Lopatin is CEO at Pardes Biosciences. Pardes Biosciences valuation.
Uri Lopatin is CEO at Pardes Biosciences (YC S20). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Public
- Education: MD from University of Medicine and Dentistry of NJ – NJ Medical School; Bachelor's degree cum laude in biology from Cornell University; Internal Medicine training at UMDNJ-New Jersey Medical School, University of Washing
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 2
- Website: http://www.pardesbio.com
Who is Uri Lopatin?
Uri Lopatin is a serial biotech entrepreneur and infectious disease physician, known for founding Pardes Biosciences (S20 YC) to develop oral antivirals. He previously co-founded Assembly Biosciences and held leadership roles at several major pharmaceutical companies.
Highlights:
- Y Combinator S20 alum and founder of Pardes Biosciences.
- Co-founded Assembly Biosciences and helped raise over $300 million for hepatitis
- Held clinical and translational science roles at Schering-Plough, Roche, and Gil
About Pardes Biosciences
We make oral drugs to treat and prevent viral infections - like COVID-19.
FAQ: Uri Lopatin net worth and Pardes Biosciences valuation
What is Uri Lopatin's net worth?
Uri Lopatin's estimated net worth is $150.0M (range $105.0M – $225.0M) as of 2026. Uri Lopatin is CEO at Pardes Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Pardes Biosciences valuation?
Pardes Biosciences's estimated valuation on Entrepreneurial Check is $2.0B. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Uri Lopatin's role?
Uri Lopatin is CEO at Pardes Biosciences, a Y Combinator-backed startup (batch S20).